non-small-cell-lung-cancer
18
Non small cell lung cancer

Non small cell lung cancer

Last Reviewed : 12/24/2020
Non small cell lung cancer

Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively (neoadjuvant chemotherapy) and post-operatively (adjuvant chemotherapy).

We researched this topic for you and found the following best online resources. They are categorized into basic, advanced, and research level based on the extent of information you need. You will be taken to the respective websites by pressing on the links below.

 

Basic information:

http://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq cancer.gov non-small-cell lung cancer

https://www.nlm.nih.gov/medlineplus/ency/article/007194.htm medline plus lung cancer - non-small cell

http://www.webmd.com/lung-cancer/guide/non-small-cell-lung-cancer web md non-small-cell lung cancer

http://umm.edu/health/medical/reports/articles/nonsmall-cell-lung-cancer university of maryland medical center non-small-cell lung cancer

http://www.healthline.com/health/lung-cancer-non-small-cell health line non-small cell lung cancer

http://my.clevelandclinic.org/health/diseases_conditions/hic_lung_cancer/hic_non-small_cell_lung_cancer cleveland clinic non-small cell lung cancer

 

Advanced information:

http://emedicine.medscape.com/article/279960-overview medscape non-small cell lung cancer

http://emedicine.medscape.com/article/279960-treatment medscape non-small cell lung cancer treatment & management

http://www.lungcancer.org/find_information/publications/163-lung_cancer_101/268-types_and_staging lung cancer.org types and staging of lung cancer

http://www.esmo.org/guidelines/lung-and-chest-tumours/metastatic-non-small-cell-lung-cancer metastatic non-small-cell lung cancer: esmo clinical practice guidelines by m. reck, s. popat, n. reinmuth, d. de ruysscher, k. m. kerr, s. peters ann oncol (2014) 25 (suppl 3): iii27-iii39.

society of nuclear medicine. "fdg pet evaluates immunotherapy for non-small cell lung cancer: molecular imaging is used to monitor a novel immunotherapy that aims to hamper tumors' ability to turn off cancer-fighting immune cells." sciencedaily. sciencedaily, 13 june 2016. www.sciencedaily.com/releases/2016/06/160613165025.htm .

http://www.genome.jp/kegg-bin/show_pathway?hsa05223 keg pathway non-small cell lung cancer - homo sapiens (human)

http://www.uptodate.com/contents/non-small-cell-lung-cancer-treatment-stage-i-to-iii-cancer-beyond-the-basics upto date patient information: non-small cell lung cancer treatment; stage i to iii cancer (beyond the basics)

 

Research:

http://europepmc.org/backend/ptpmcrender.fcgi?accid=pmc3306389&blobtype=pdf : kuo c-h, lo c-y, chung f-t, lee k-y, lin s-m, et al. (2012) concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country. plos one 7(3): e33226. doi:10.1371/journal.pone.0033226

http://europepmc.org/backend/ptpmcrender.fcgi?accid=pmc4408055&blobtype=pdf zhu l, yu h, liu s-y, xiao x-s, dong w-h,chen y-n, et al. (2015) prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non–small cell lung cancer: a systematic review and meta-analysis. plos one 10(4): e0124230. doi:10.1371/journal.pone.0124230

http://journal.frontiersin.org/article/10.3389/fonc.2014.00182/full mini review article front. oncol., 16 july 2014 | http://dx.doi.org/10.3389/fonc.2014.00182 non-small cell lung carcinoma biomarker testing: the pathologist’s perspective by elisa brega and guilherme brandao

http://web.imu.edu.my/ejournal/approved/ejournal_2.2_23-26.pdf pet-ct imaging in non-small cell lung carcinoma – a review of cases from a northern malaysia referral centre by joni bing fei teoh et al., iejsme 2008: 2 (2): 23-26

http://europepmc.org/backend/ptpmcrender.fcgi?accid=pmc4783083&blobtype=pdf : hu x, pu k, feng x, wen s, fu x, guo c,et al. (2016) role of gemcitabine and pemetrexed as maintenance therapy in advanced nsclc:a systematic review and meta-analysis of randomized controlled trials. plos one 11(3):e0149247. doi:10.1371/journal.pone.0149247

desai c, mehta a, mishra d. usage patterns of biomarkers in non-small-cell lung cancer patients in india: findings from a systematic review and survey. lung india [serial online] 2014 [cited 2016 jul 1];31:249-59. available from: http://www.lungindia.com/text.asp?2014/31/3/249/135767

http://www.nejm.org/doi/full/10.1056/nejmoa060096#t=article a five-gene signature and clinical outcome in non–small-cell lung cancer by hsuan-yu chen, m.sc et al., n engl j med 2007; 356:11-20january 4, 2007doi: 10.1056/nejmoa060096

http://oncology.jamanetwork.com/article.aspx?articleid=2513900 prognostic and predictive value in kras in non–small-cell lung cancera review by kevin wood, md jama oncol. 2016;2(6):805-812. doi:10.1001/jamaoncol.2016.0405.

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-016-0246-5 emerging roles of nrf2 signal in non-small cell lung cancer by yijun tian et al., journal of hematology & oncology20169:14 doi: 10.1186/s13045-016-0246-5

http://err.ersjournals.com/content/22/127/33 nonsmall cell lung cancer by jean-paul sculier european respiratory review 2013 22: 33-36; doi: 10.1183/09059180.00007012

http://www.omicsonline.org/tp53-is-a-mutational-target-in-non-small-cell-lung-cancer-patients-2157-2518.1000138.php?aid=11703 alpana s, javid j, mir r, masroor m, ahamad i, et al. (2013) tp53 is a mutational target in non small cell lung cancer patients and its pro/pro variant is potentially contributing to cancer susceptibility. j carcinogene mutagene 4:138. doi: 10.4172/2157-2518.1000138

http://medind.nic.in/iae/t04/i3/iaet04i3p191.pdf non small cell lung cancer (nsclc): current status and future prospects by a.k. pathak, m. bhutani et al., indian j chest dis allied sci 2004; 46 : 191-203

http://www.atsjournals.org/doi/full/10.1513/pats.200809-107lc#.v4tsldkuesq gregory j. riely, jenifer marks, and william pao "kras mutations in non–small cell lung cancer", proceedings of the american thoracic society, vol. 6, no. 2 (2009), pp. 201-205.

 

Related videos:

https://www.youtube.com/watch?v=j5ufbv18bis the pathophysiology of non-small cell lung cancer

https://www.youtube.com/watch?v=iwozzqa3l7c lung cancer staging non-small cell

https://www.youtube.com/watch?v=8kqvbfq0yzo lung cancer (small cell lung carcinoma and non-small cell lung carcinoma) for usmle 2

https://www.youtube.com/watch?v=lvtgdmxzxje non small cell lung cancer overview

https://www.youtube.com/watch?v=rtn712ukew8 the role of immunotherapy in non small cell lung cancer nsclc

https://www.youtube.com/watch?v=qdfwqhtylvq nivolumab in non-small cell lung cancer

https://www.youtube.com/watch?v=zpitrq9gzaa vats lobectomy for the treatment of non-small cell lung cancer

 

Presentations/quiz/newspaper articles:

http://www.medgadget.com/2016/07/lung-cancer-therapeutics-market-development-size-share-growth-and-demand-forecast-to-2015-2021.html medgadget lung cancer therapeutics market : development, size, share, growth and demand forecast to 2015 – 2021

http://www.dailyrecord.co.uk/news/scottish-news/first-new-lung-cancer-drugs-8401818#qy94zmc7i4jdkloj.97 daily record first new lung cancer drugs in 20 years approved for use in scotland
read more at http://www.dailyrecord.co.uk/news/scottish-news/first-new-lung-cancer-drugs-8401818#ecuxtewwcwx4iu2y.99

http://www.scotsman.com/news/lung-cancer-treatments-approved-for-scottish-nhs-1-4174751 the scotsman lung cancer treatments approved for scottish nhs

Please leave your comments:



Related Articles